N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
US8859577B2 · kind B2 · utility
7Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2011 |
| Grant date | Oct 14, 2014 |
| Priority date | — |
| Expiry date | Sep 20, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound of Formula (I) Z N N O N O A1R2 R1 R3R 3 L A2 (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3,Z, A1, L and A 5 2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.